KCI launches new app to help physicians become aware of cutting-edge cancer clinical trials

The Barbara Ann Karmanos Cancer Institute (KCI) today announced its new app to help physicians and healthcare professionals become aware of cutting-edge cancer clinical trials, often available only at Karmanos. The KCI Trials App is free and available on the App Store(SM) for the iPhone® and iPad®.

"It is important that physicians are familiar with new treatment options available through our Clinical Trials Program at the Karmanos Cancer Institute," said Connie Claybaker, associate center director, Research Administration, Karmanos Cancer Institute.

According to Claybaker, Karmanos' clinical trials portfolio includes some of the most exciting new investigational agents for cancer patients. The scientific advances Karmanos researchers make every day bring safe and ground breaking treatments from the laboratory bench to the patient's bedside, defining the new standards of cancer care. 

"The ultimate goal is to make it as easy as possible for referring physicians and other healthcare professionals to find a clinical trial that may benefit their patients," said Karmanos' Anthony Shields, M.D., Ph.D., associate center director, Clinical Sciences. "With this app, a physician could be meeting with the patient and quickly identify a clinical trial that offers a possible new treatment for consideration."

The new app allows users to search for cancer clinical trials by disease site, keyword, protocol number, phase, or principal investigator. The information displayed for each trial includes the title, objective, principal investigator, disease sites, drugs involved, and eligibility criteria. Plus, users have the option to save protocol information to their 'favorites' and email protocol information to a colleague or patient directly from the app.

Additional features include buttons to call and email Karmanos Cancer Institute directly, information about Phase I studies offered and links to National Cancer Institute resources about cancer.

Source: http://www.karmanos.org

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Pitt study uncovers a novel trigger of deadly form of ovarian cancer